ATE409475T1 - Behandlung von fibromyalgie mit pindolol - Google Patents

Behandlung von fibromyalgie mit pindolol

Info

Publication number
ATE409475T1
ATE409475T1 AT02805691T AT02805691T ATE409475T1 AT E409475 T1 ATE409475 T1 AT E409475T1 AT 02805691 T AT02805691 T AT 02805691T AT 02805691 T AT02805691 T AT 02805691T AT E409475 T1 ATE409475 T1 AT E409475T1
Authority
AT
Austria
Prior art keywords
pindolol
treating fibromyalgia
fibromyalgia
treating
antagonist
Prior art date
Application number
AT02805691T
Other languages
English (en)
Inventor
T G Dinan
P W N Keeling
Original Assignee
Dinan Timothy Gerard
P W N Keeling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dinan Timothy Gerard, P W N Keeling filed Critical Dinan Timothy Gerard
Application granted granted Critical
Publication of ATE409475T1 publication Critical patent/ATE409475T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02805691T 2001-02-20 2002-02-20 Behandlung von fibromyalgie mit pindolol ATE409475T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26993701P 2001-02-20 2001-02-20

Publications (1)

Publication Number Publication Date
ATE409475T1 true ATE409475T1 (de) 2008-10-15

Family

ID=27734142

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02805691T ATE409475T1 (de) 2001-02-20 2002-02-20 Behandlung von fibromyalgie mit pindolol

Country Status (5)

Country Link
US (2) US6855729B2 (de)
EP (1) EP1383496B1 (de)
AT (1) ATE409475T1 (de)
DE (1) DE60229123D1 (de)
WO (1) WO2003065970A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7417038B1 (en) * 1998-10-15 2008-08-26 Imperial Innovations Limited Methods of treating cachexia
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
US20080262071A1 (en) * 2004-09-17 2008-10-23 Timothy Dinan Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder
JP2008513430A (ja) * 2004-09-17 2008-05-01 ニューロキュア リミテッド 月経前症候群および月経前不快気分障害の処置のためのピンドロール
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
GB0624282D0 (en) * 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
GB0907350D0 (en) * 2009-04-29 2009-06-10 Myotec Therapeutics Ltd Methods
JP2012526832A (ja) * 2009-05-13 2012-11-01 スノビオン プハルマセウトイカルス インコーポレイテッド トランスノルセルトラリン及びセロトニン受容体１ａ作動剤／拮抗剤を含む組成物及びその使用
CN112955145A (zh) 2018-09-04 2021-06-11 密涅瓦神经科学有限公司 使用苯氧丙胺化合物治疗疼痛的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (de) * 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
US5895787A (en) * 1997-10-08 1999-04-20 Designed Nutritional Products, Inc. Treatment of fibromyalgia and related disorders
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
DE69903992T2 (de) * 1998-04-15 2003-08-21 Pfizer Products Inc., Groton Heterocyclische Carboxamide
US6331571B1 (en) * 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)

Also Published As

Publication number Publication date
US20040214877A1 (en) 2004-10-28
EP1383496B1 (de) 2008-10-01
WO2003065970A2 (en) 2003-08-14
US20020165263A1 (en) 2002-11-07
WO2003065970A3 (en) 2003-11-20
EP1383496A2 (de) 2004-01-28
US6855729B2 (en) 2005-02-15
DE60229123D1 (de) 2008-11-13

Similar Documents

Publication Publication Date Title
CY1117485T1 (el) Πολυθεραπεια για β-λεμφοκυτταρικες διαταραχες
CY1111194T1 (el) Ενωσεις πιπεριδινυλιου που επιλεκτικα προσδενουν ιντεγρινες
CY1109295T1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
PL372372A1 (en) Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
DE69737592D1 (de) Mittel gegen juckreiz
EA200000349A1 (ru) Способ лечения оппозиционного расстройства
DE60005688D1 (de) Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer
DE602005020799D1 (de) Humanisierte anti-cmet-antagonisten
CY1110225T1 (el) Κυκλικοι αναστολεις πρωτεϊνικης τυροσινικης κινασης
EA200500520A1 (ru) Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов
DK1355889T3 (da) Substituerede triazoldiaminderivater som kinaseinhibitorer
ATE552856T1 (de) Selektive norepinephrin-serotonin- wiederaufnahmehemmer zur behandlung des fibromyalgie-syndroms, des chronischen müdigkeitssyndroms und von schmerzen
NO20020837D0 (no) Fremgangsmåte til å identifisere egenskaper til stoff som påvirker prostaglandin D reseptorer
EA200000351A1 (ru) Лечение кондуктивных нарушений
NO20056134L (no) Kombinasjon av en NMDA-reseptorantagonist og en selektiv serotoningjenopptaksinbibitor for behandling av depresjon og andre sinnsstemningsforstyrrelser
DK1427409T3 (da) Fremgangsmåde til behandling eller forhindring af vaskulær inflammation under brug af en eller flere sterolabssorptionsinhibitorer
ATE406159T1 (de) Behandlung von hyperlipidämie
EA200401160A1 (ru) Производные тиазола и оксазола, которые модулируют активность ppar
NO20040211L (no) Kombinasjon av en aldosteronreseptor for antagonist og en HMB COA-reduktaseinhibitor
ATE409475T1 (de) Behandlung von fibromyalgie mit pindolol
EA200500783A1 (ru) Комбинация для лечения синдрома дефицита внимания с гиперактивностью
DE602004004883D1 (de) Vegf-antagonisten zur behandlung von diabetes
ATE376419T1 (de) Carbostyril-derivate mit selektiven serotonin- aufnahme inhibitoren, zur behandlung von gemütskrankheiten
EA200500770A1 (ru) Конденсированные гетероциклические соединения
FI20031191A7 (fi) Monoamiinin takaisinoton estäjä

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties